Joel Morse has devoted his career to building innovative companies that serve the pharmaceutical industry. His latest venture, Curavit Clinical Research runs decentralized or virtual trials, which have gotten huge in the pandemic.

In this episode of the HealthBiz podcast, Joel talks about decentralized trials and why they’re growing. He also opens up about his experience building C3i, and how it led him to adventures around the world, including Joel’s involvement with the royal family in Bulgaria.

As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
YouTube https://www.youtube.com/@CareTalkPodcast
CareTalk website https://www.caretalkpodcast.com/

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.

Curavit CEO Joel Morse on virtual clinical trials